Netherlands· NL-3a593ce19b30

Exemestaan Synthon 25 mg, filmomhulde tabletten

A exemestane product containing exemestaan, registered in Netherlands by Synthon B.V.. The same ATC class is registered in 17 of our 19 countries.

ATC L02BG06

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about exemestaanAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Exemestane is registered in 17 of 19 countries.

Countries holding a registration under ATC L02BG06 (exemestane), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
10 of them publish a price we can compare per daily dose

Search exemestane products by name

Exemestane · ATC L02BG06

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of exemestane costs, country by country.

Normalised to the WHO defined daily dose (25 mg), the median price runs from $1.43 in France to $3.32 in Switzerland — a ×2.3 gap.

3 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Exemestane · price per daily dose (25 mg)

USD · FX 28 Sept 2026

CH Switzerland$3.32
IT Italy$2.46
FR France$1.43

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: EXEMESTAAN
Manufacturer: Synthon B.V.
Country: Netherlands (NL)
ATC code: L02BG06
ATC class: Exemestane
Defined daily dose: 25 mg, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
118538

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

236 interactions on record for exemestane.

Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check exemestane against other medicines How interaction checks work

Exemestane · interactions on record

236 records

1 severe
83 moderate
152 info

Most severe, free to view

ThalidomideL04AX02severe
TroglitazoneA10BG01moderate
SulfinpyrazonB01AC12moderate
FostamatinibB02BX09moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Exemestane in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All exemestane products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Aromasin, Exemestan Accord
Belgium · Aromasin, Exemestan Sandoz
Bulgaria · Аромазин, Екземегратис
Cyprus · Exedral
Czechia · Aromasin, Astexana
Germany · Aromasin, Exemestan 1 A Pharma
Denmark · Aromasin, Exemestan Accord
Estonia · Aromasin, Exemestane Accord
Spain · Aromasil, Exemestano Aurovitas
Finland · Aromasin, Exemestan Pfizer
France · Aromasine, Exemestane Accord
United Kingdom (Northern Ireland) · Aromasin, Exemestane
Greece · Aromaplex, Aromasin
Croatia · Aromasin, Eksemestan Jgl
Hungary · Aromasin, Exemestane Pharmacenter
Ireland · Aromasin, Exemestane Accord
Iceland · Aromasin, Exemestan Actavis
Italy · Aromasin, Axelta
Lithuania · Aromasin, Exemestane Accord
Luxembourg · Aromasin, Exemestan Ratiopharm
Latvia · Exemestane Accord, Exemestane Sanoswiss
Malta · Aromasin, Exedral 25
Norway · Aromasin, Exemestan Sandoz
Poland · Astexana, Glandex
Portugal · Aromasin, Exemestano Accord
Romania · Aromasin, Exemestan Accord
Sweden · Exemestan Actavis, Exemestan Sandoz
Slovenia · Aromasin
Slovakia · Aromasin, Astexana

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/e62af892-5b77-4e8a-82c4-82d97d76e543
GET /v1/drugs/e62af892-5b77-4e8a-82c4-82d97d76e543?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h118538_smpc.pdf",
  "strength": null,
  "atc_label": "Exemestane",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg118538",
  "excipients": [
    "CARMELLOSE NATRIUM (E 466)",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSPOVIDON (E 1202)",
    "GLUCOSE 1-WATER",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "IJZEROXIDE GEEL (E 172)",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MALTODEXTRINE",
    "MANNITOL (D-) (E 421)",
    "NATRIUMZETMEELGLYCOLAAT",
    "POLYSORBAAT 80 (E 433)",
    "SILICIUMDIOXIDE (E 551)",
    "STEARINEZUUR (E 570)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "EXEMESTAAN"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h118538.pdf",
  "authorised_at": "2016/01/25",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "118538",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about exemestane.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console